Tandem Diabetes Care (TNDM) Gross Margin (2013 - 2026)
Tandem Diabetes Care (TNDM) reported Gross Margin of 55.33% for Q1 2026, up 482.0% on a YoY basis from 9.51% in Q1 2025, and down 4.05% quarter-over-quarter from 57.67% in Q4 2025.
Tandem Diabetes Care (TNDM) Gross Margin (2013 - 2026) Analysis & Trends
Tandem Diabetes Care has reported Gross Margin for 14 years, with the latest figure at 55.33% in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin rose 482.0% year-over-year to 55.33%; the trailing twelve-month figure through Mar 2026 stood at 54.93% (up 271.0% YoY), and the FY2025 full-year result was 53.81%, up 174.0% from the prior year.
- Gross Margin for Q1 2026 stood at 55.33%, down from 57.67% in the prior quarter.
- The five-year high for Gross Margin was 57.67% in Q4 2025, with the low at 47.41% in Q4 2023.
- Historically, Gross Margin has averaged 51.73% across 5 years, with a median of 51.09% in 2024.
- Annual changes were most pronounced in 2023 — Gross Margin tumbled 498 bps — and 2024, when it surged 830 bps.
- Tandem Diabetes Care's Gross Margin stood at 52.39% in 2022, then slipped by 10 bps to 47.41% in 2023, then rose by 18 bps to 55.71% in 2024, then gained by 4 bps to 57.67% in 2025, then retreated by 4 bps to 55.33% in 2026.
- The last three Gross Margin figures came in at 55.33% (Q1 2026), 57.67% (Q4 2025), and 53.88% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 63.83% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 78.01% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 38.53% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 45.22% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 62.95% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 43.89% |
| 10 | Tandem Diabetes Care | 1.13 Bn | 557.61 Mn | 136.79 Mn | 55.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.33% |
| Dec 31, 2025 | 57.67% |
| Sep 30, 2025 | 53.88% |
| Jun 30, 2025 | 52.29% |
| Mar 31, 2025 | 50.51% |
| Dec 31, 2024 | 55.71% |
| Sep 30, 2024 | 51.09% |
| Jun 30, 2024 | 50.83% |
| Mar 31, 2024 | 49.39% |
| Dec 31, 2023 | 47.41% |
| Sep 30, 2023 | 48.35% |
| Jun 30, 2023 | 51.93% |
| Mar 31, 2023 | 48.95% |
| Dec 31, 2022 | 52.39% |
| Sep 30, 2022 | 51.05% |
| Jun 30, 2022 | 50.91% |
| Mar 31, 2022 | 51.78% |
| Dec 31, 2021 | 54.16% |
| Sep 30, 2021 | 53.86% |
| Jun 30, 2021 | 53.71% |